🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Status
Completed
Location
AZ Sint-Jan
Start Date
2003-11
Trial ID
NCT00077116
In this trial the effects of the inhaled drug BAY1237592 will be studied in...
Status
Completed
Location
Medizinische Universität Graz
Start Date
2019-01-21
Trial ID
NCT03754660
Treatments Being Tested
Study hypothesis: Simultaneous FMC-Alemtuzumab administration followed by A...
Status
Completed
Location
University Hospital Cologne
Start Date
2010-06
Trial ID
NCT01186640
Treatments Being Tested
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested
The purpose of this research study is to determine how well pertuzumab and ...
Status
Terminated
Location
Duke University Medical Center
Start Date
2017-05-01
Trial ID
NCT02598427
Treatments Being Tested
Background: Colorectal cancer is a common cancer in the Unites States (U.S...
Status
Terminated
Location
Lombardi Comprehensive Cancer Center
Start Date
2017-04-05
Trial ID
NCT03050814
RATIONALE: Monoclonal antibodies, such as rituximab and yttrium Y 90 ibritu...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2003-11
Trial ID
NCT00070447
This study will evaluate the efficacy, safety and patient reported outcomes...
Status
Unknown
Location
Multiple Locations
Start Date
2020-09-01
Trial ID
NCT04516655
Treatments Being Tested
Background: The disease follicular lymphoma (FL) develops when the body ma...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-22
Trial ID
NCT03789240
RATIONALE: Monoclonal antibodies, such as epratuzumab and rituximab, can bl...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2006-01
Trial ID
NCT00301821
Treatments Being Tested